<table border="none" frame="void" id="ID_118E7423-3719-4492-B63D-A67DE642051B" width="449.9960000000001" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption id="ID_DE7EDC46-EA7C-4727-A294-0DE036C27AD7">TABLE 1 Summary of Effectiveness Data in Placebo-Controlled Trials</caption>
<col width="26.667%"></col>
<col width="12.222%"></col>
<col width="12.222%"></col>
<col width="12.222%"></col>
<col width="12.222%"></col>
<col width="12.222%"></col>
<col width="12.222%"></col>
<tfoot id="ID_61C764E1-EF82-4E46-A145-CB3F9B6EAD0D">
<tr><td align="left" colspan="7" valign="top"><rendermultimedia referencedobject="ID_D9DED80E-BA0C-4158-9B6E-162ED2A10800"></rendermultimedia><br/>a AUA questionnaire (range 0-30) in studies 1 and 3. Modified Boyarsky Questionnaire (range 7-39) in study 2.<br/>b Change is to endpoint. <br/>c Change is fixed-dose efficacy phase, 22-26 hours post-dose for studies 1 and 3 and 2-6 hours post-dose for study 2. <br/>d Study in hypertensives with BPH. <br/>e 36 patients received a dose of 8 mg doxazosin mesylate.<br/>* (**) p&lt;0.05 (0.01) compared to placebo mean change.</td></tr>
</tfoot>
<tbody>
<tr id="ID_A83C10C9-B3FE-42CB-9FDE-552DE556DF5F"><td align="left" valign="top"></td><td align="left" colspan="3" valign="top"><content stylecode="bold"><content stylecode="emphasis">Symptom ScoreÂ </content></content><content stylecode="bold"><content stylecode="emphasis"><sup>a</sup></content></content></td><td align="left" colspan="3" valign="top"><paragraph><content stylecode="bold"><content stylecode="emphasis">Maximum Flow Rate</content></content></paragraph><content stylecode="bold"><content stylecode="emphasis">(mL/sec)</content></content></td></tr>
<tr id="ID_3C6DEE6C-A6E6-4240-9B29-40797E8B0991"><td align="left" valign="top"></td><td align="left" valign="top"><content stylecode="bold"><content stylecode="emphasis">N</content></content></td><td align="left" valign="top"><paragraph><content stylecode="bold"><content stylecode="emphasis">Mean</content></content></paragraph><content stylecode="bold"><content stylecode="emphasis">Baseline</content></content></td><td align="left" valign="top"><paragraph><content stylecode="bold"><content stylecode="emphasis">Mean<sup>b</sup></content></content></paragraph><content stylecode="bold"><content stylecode="emphasis">Change</content></content></td><td align="left" valign="top"><content stylecode="bold"><content stylecode="emphasis">N</content></content></td><td align="left" valign="top"><paragraph><content stylecode="bold"><content stylecode="emphasis">Mean</content></content></paragraph><content stylecode="bold"><content stylecode="emphasis">Baseline</content></content></td><td align="left" valign="top"><paragraph><content stylecode="bold"><content stylecode="emphasis">Mean<sup>c</sup></content></content></paragraph><content stylecode="bold"><content stylecode="emphasis">Change</content></content></td></tr>
<tr id="ID_AB2EF5B9-1819-4E32-928C-665DA7BD12ED"><td align="left" colspan="7" valign="top"><paragraph><content stylecode="bold"><content stylecode="emphasis">Study 1 (Titration to</content></content></paragraph><content stylecode="bold"><content stylecode="emphasis">maximum dose of 8 mg)<sup>e</sup></content></content></td></tr>
<tr id="ID_E9DC0A15-B210-4617-977F-25B42047A7DA"><td align="left" valign="top">Placebo</td><td align="left" valign="top">47</td><td align="left" valign="top">15.6</td><td align="left" valign="top">-2.3</td><td align="left" valign="top">41</td><td align="left" valign="top">9.7</td><td align="left" valign="top">+0.7</td></tr>
<tr id="ID_A132280D-5789-49A8-8557-5E1935FD5A4A"><td align="left" valign="top">Doxazosin mesylate</td><td align="left" valign="top">49</td><td align="left" valign="top">14.5</td><td align="left" valign="top">-4.9**</td><td align="left" valign="top">41</td><td align="left" valign="top">9.8</td><td align="left" valign="top">+2.9**</td></tr>
<tr id="ID_16742C94-91D8-41F9-986D-4903ED61B1E6"><td align="left" colspan="7" valign="top"><paragraph><content stylecode="bold"><content stylecode="emphasis">Study 2 (Titration to</content></content></paragraph><content stylecode="bold"><content stylecode="emphasis">fixed dose - 14 weeks)<sup>d</sup></content></content></td></tr>
<tr id="ID_2F18A1AB-E0A6-4519-BFC4-7BB24575AFB8"><td align="left" valign="top">Placebo</td><td align="left" valign="top">37</td><td align="left" valign="top">20.7</td><td align="left" valign="top">-2.5</td><td align="left" valign="top">30</td><td align="left" valign="top">10.6</td><td align="left" valign="top">+0.1</td></tr>
<tr id="ID_86D1B6C3-38C2-4F87-9DF8-82EAA3C2D738"><td align="left" valign="top">Doxazosin mesylate 4 mg</td><td align="left" valign="top">38</td><td align="left" valign="top">21.2</td><td align="left" valign="top">-5.0**</td><td align="left" valign="top">32</td><td align="left" valign="top">9.8</td><td align="left" valign="top">+2.3*</td></tr>
<tr id="ID_C4A28224-C103-4E0C-98DE-F1672911802E"><td align="left" valign="top">Doxazosin mesylate 8 mg</td><td align="left" valign="top">42</td><td align="left" valign="top">19.9</td><td align="left" valign="top">-4.2*</td><td align="left" valign="top">36</td><td align="left" valign="top">10.5</td><td align="left" valign="top">+3.3**</td></tr>
<tr id="ID_A3746140-0503-4005-B4C1-5AC0265FF05D"><td align="left" colspan="7" valign="top"><paragraph><content stylecode="bold"><content stylecode="emphasis">Study 3 (Titration to</content></content></paragraph><content stylecode="bold"><content stylecode="emphasis">fixed dose - 12 weeks)</content></content></td></tr>
<tr id="ID_3C6FF25C-D5DF-4F6C-BC35-E2A643A77D74"><td align="left" valign="top">Placebo</td><td align="left" valign="top">47</td><td align="left" valign="top">14.9</td><td align="left" valign="top">-4.7</td><td align="left" valign="top">44</td><td align="left" valign="top">9.9</td><td align="left" valign="top">+2.1</td></tr>
<tr id="ID_9CABD4F8-A786-47ED-B6A2-F1F18989ED76"><td align="left" valign="top">Doxazosin mesylate 4 mg</td><td align="left" valign="top">46</td><td align="left" valign="top">16.6</td><td align="left" valign="top">-6.1*</td><td align="left" valign="top">46</td><td align="left" valign="top">9.6</td><td align="left" valign="top">+2.6</td></tr>
</tbody>
</table>